Present invention relates to an improved and commercial process for the preparation of lacosamide ((R)-2-acetami-do-N-benzyl-3-methoxypropanamide) of formula (I). Present process utilizes high purity crystalline solids of formulae (XXXII) and (XIII) as key intermediates. Lacosamide is indicated for the adjunctive treatment of partial onset seizures in patients aged at least 17 years.
本发明涉及一种改进的商业化过程,用于制备拉考酰胺((R)-2-乙酰胺基-N-苄基-3-甲氧基丙酰胺)的
化学式(I)。目前的工艺利用
化学式(XXXII)和(XIII)的高纯度结晶固体作为关键中间体。拉考酰胺适用于至少17岁的患者的部分发作性癫痫的辅助治疗。